Drug details

Dantrium IV (dantrolene sodium for injection)

type of

Dantrium Intravenous (dantrolene sodium) is a skeletal muscle relaxant mainly used in as an emergency treatment for malignant hyperthermia, which is a rare reaction to medications (mainly anesthetics). Dantrium Intravenous is available in generic form.

This drug may have the following side effects:
  • nausea,
  • headache,
  • sweating,
  • dizziness,
  • vomiting,
  • diarrhea,
  • sleep problems (insomnia),
  • constipation,
  • muscle weakness,
  • stomach pain,
  • drowsiness,
  • confusion, 
  • vision problems, 
  • problems with speech,
  • tired feeling,
  • low energy,
  • injection site reactions (pain, redness, or swelling),
  • difficulty with balance or walking,
  • drooling, or
  • urinating more than usual
The following drugs are related to Dantrium IV, either as a replacement or used together:
  • Lemtrada (alemtuzumab injection for intravenous infusion)
  • Ampyra (dalfampridine extended-release tablets)
  • Aubagio (teriflunomide tablets)
  • Avonex (interferon beta-1a)
  • Betaseron (interferon beta-1b)
  • Copaxone (glatiramer acetate)
  • Cuvposa (glycopyrrolate oral solution)
  • Revonto (dantroene sodium injection)
  • Ryanodex (dantrolene sodium injectable suspension)
  • Tecfidera (dimethyl fumarate delayed release capsules)
  • H.P. Acthar Gel (repository corticotropin injection)
  • Rebif (interferon beta-1a)
  • Novantrone (mitoxantrone for injection concentrate)
  • Tysabri (natalizumab)
The following supplements are related to Dantrium IV, and may be used together with the drug:
  • Marijuana (s.)
  • Superoxide Dismutase (s.)
  • Mesoglycan (s.)